Comparison of cilostazol versus ticlopidine therapy after stent implantation.

[1]  Y. Matsumoto,et al.  Antiplatelet treatment with cilostazol after stent implantation , 1998, Heart.

[2]  D. Dawson,et al.  Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. , 1998, Circulation.

[3]  S. King,et al.  The development of interventional cardiology. , 1998, Journal of the American College of Cardiology.

[4]  M. Murayama,et al.  A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation. , 1997, Clinical therapeutics.

[5]  S. Takeshita,et al.  Use of cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting regimen. , 1997, The American journal of cardiology.

[6]  T. Iwasaka,et al.  Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty. , 1997, The American journal of cardiology.

[7]  G. Roubin,et al.  Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. , 1996, The American journal of cardiology.

[8]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[9]  M. Brack,et al.  Anticoagulation after intracoronary stent insertion. , 1994, British heart journal.

[10]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[11]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[12]  M. Murata,et al.  Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study. , 1987, Arzneimittel-Forschung.

[13]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[14]  M. Hagiwara,et al.  Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. , 1988, Pharmacology.

[15]  R. Roncucci,et al.  Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications. , 1983, Haemostasis.